Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

OncoSec Medical Inc. And Plexxikon Inc. Collaborate To Explore Combination Immunotherapy In Preclinical Tumor Studies

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced a preclinical collaboration with Plexxikon Inc., a member of the Daiichi Sankyo Group and leader in the discovery and development of novel small molecule pharmaceuticals, to test the combination of Plexxikons selective CSF-1R inhibitor with OncoSecs Immunopulse…

International Stem Cell Corporation To Present Preclinical Parkinson’s Disease Data At

November 17, 2014 – 5:00 pm | Edit Post

Safety and Efficacy Data From Company’s Human Neural Stem Cells Featured in Neuroscience 2014 Press Program “Advances Through Stem Cell Research” CARLSBAD, CA–(November 18, 2014) – International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today preclinical data from its Parkinson…

ResMed Inc.’s New S+ Consumer Sleep Monitor Now Integrates With Apple HealthKit

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 18, 2014 /PRNewswire/ — ResMed (NYSE: RMD), a leading innovator in sleep, recently launched the all-new S, the world’s first non-contact, personal sleep monitoring device. ResMed today announced S availability through Apple retail stores in the United States

Isis Pharmaceuticals, Inc. To Host Webcast To Discuss ISIS-FXI Rx Data Presented At The American Society of Hematology Annual Meeting

November 17, 2014 – 5:00 pm | Edit Post

CARLSBAD, Calif., Nov. 18, 2014 /PRNewswire/ –Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will host a live webcast on Monday, December 8, 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXIRx data presented at the…

International Stem Cell Corporation To Present Preclinical Parkinson’s Disease Data At

November 17, 2014 – 5:00 pm | Edit Post

Safety and Efficacy Data From Company’s Human Neural Stem Cells Featured in Neuroscience 2014 Press Program “Advances Through Stem Cell Research” CARLSBAD, CA–(November 18, 2014) – International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today preclinical data from its Parkinson…

Isis Pharmaceuticals, Inc. To Host Webcast To Discuss ISIS-FXI Rx Data Presented At The American Society of Hematology Annual Meeting

November 17, 2014 – 5:00 pm | Edit Post

CARLSBAD, Calif., Nov. 18, 2014 /PRNewswire/ –Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will host a live webcast on Monday, December 8, 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXIRx data presented at the…

Aurora Spine Receives FDA 510(k) Clearance For Pre-Packaged Sterile ZIP 51 MIS Interspinous Fixation Implant

November 17, 2014 – 5:00 pm | Edit Post

Aurora Spine Receives FDA 510(k) Clearance for Pre-Packaged Sterile ZIP 51(TM) MIS Interspinous Fixation ImplantCARLSBAD, CALIFORNIA–(Marketwired – Nov 18, 2014) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZIP 51, Aurora Spine’s slimmest minimally invasive…

Organovo Announces Commercial Release Of The exVive3D??? Human Liver Tissue

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 18, 2014 /PRNewswire/ — Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced the full commercial release of the exVive3DTM Human Liver Tissue for preclinical drug discovery…

Aurora Spine Receives FDA 510(k) Clearance For Pre-Packaged Sterile ZIP 51 MIS Interspinous Fixation Implant

November 17, 2014 – 5:00 pm | Edit Post

Aurora Spine Receives FDA 510(k) Clearance for Pre-Packaged Sterile ZIP 51(TM) MIS Interspinous Fixation ImplantCARLSBAD, CALIFORNIA–(Marketwired – Nov 18, 2014) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZIP 51, Aurora Spine’s slimmest minimally invasive…

Safety And Feasibility Of Cytori Therapeutics, Inc. Cell Therapy In Acute Myocardial Infarction Presented At 2014 American Heart Association Meeting

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Data was presented at the American Heart Association meeting in Chicago on November 17, 2014 regarding the safety and feasibility of Cytori Cell Therapy using Adipose Derived Regenerative Cells (ADRCs) administered through the coronary artery in patients with acute ST segment elevated myocardial infarction from the ADVANCE clinical trial sponsored by Cytori Therapeutics…